Sort   by:  
 Page size 
UnknownComparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).
Not available
S-EPMC4105484 | biostudies-literature
UnknownValidation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer.
Not available
S-EPMC5321104 | biostudies-literature
UnknownQuality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years.
Not available
S-EPMC5815404 | biostudies-literature
UnknownSix cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101.
Not available
S-EPMC3494835 | biostudies-literature
Sort   by:  
 Page size